BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lohse AW, Mieli-Vergani G. Autoimmune hepatitis. J Hepatol. 2011;55:171-182. [PMID: 21167232 DOI: 10.1016/j.jhep.2010.12.012] [Cited by in Crossref: 121] [Cited by in F6Publishing: 99] [Article Influence: 10.1] [Reference Citation Analysis]
Number Citing Articles
1 Hübener S, Oo YH, Than NN, Hübener P, Weiler-normann C, Lohse AW, Schramm C. Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance. Clinical Gastroenterology and Hepatology 2016;14:445-53. [DOI: 10.1016/j.cgh.2015.09.037] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 9.8] [Reference Citation Analysis]
2 Franco M, Monmany J, Domingo P, Turbau M. Hepatitis autoinmune desencadenada tras el consumo de bayas de Goji. Medicina Clínica 2012;139:320-1. [DOI: 10.1016/j.medcli.2012.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
3 de Albuquerque MS, Rizuto AV, de Araújo Silva Tavares ÁF, Nascimento AS, de Souza Araújo PR, de Lima EA, Braz da Silva R. Treatment of an Acute Apical Abscess in a Patient With Autoimmune Hepatitis Taking Alendronate: A Case Report. Journal of Endodontics 2019;45:1550-5. [DOI: 10.1016/j.joen.2019.09.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Tannapfel A, Dienes HP, Lohse AW. The indications for liver biopsy. Dtsch Arztebl Int. 2012;109:477-483. [PMID: 22833761 DOI: 10.3238/arztebl.2012.0477] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
5 Woynarowski M, Woźniak M, Cukrowska B, Wierzbicka A, Lytton SD. Autoantibody Profile of Adult Patients With Childhood Onset Type 2 Autoimmune Hepatitis. J Clin Lab Anal 2016;30:590-6. [PMID: 26676069 DOI: 10.1002/jcla.21907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Wang G, Tanaka A, Zhao H, Jia J, Ma X, Harada K, Wang FS, Wei L, Wang Q, Sun Y, Hong Y, Rao H, Efe C, Lau G, Payawal D, Gani R, Lindor K, Jafri W, Omata M, Sarin SK. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int 2021;15:223-57. [PMID: 33942203 DOI: 10.1007/s12072-021-10170-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
7 Guo L, Zheng L, Hu L, Zhou H, Yu L, Liang W. Transient Elastography (FibroScan) Performs Better Than Non-Invasive Markers in Assessing Liver Fibrosis and Cirrhosis in Autoimmune Hepatitis Patients. Med Sci Monit 2017;23:5106-12. [PMID: 29073121 DOI: 10.12659/msm.907300] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
8 Liu M, Zhang H, Zhang L, Liu X, Zhou S, Wang X, Zhong W, Zhang J, Wang B, Zhao J, Zhou L. RIP3 blockade prevents immune-mediated hepatitis through a myeloid-derived suppressor cell dependent mechanism. Int J Biol Sci 2022;18:199-213. [PMID: 34975327 DOI: 10.7150/ijbs.65402] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Vinnitskaya EV, Sandler YG, Bakulin IG, Parfenov AI, Ilchenko LY, Nikitin IG, Bueverov AO, Lopatkina TN, Ignatova ТМ, Syutkin VY, Raikhelson KL, Khomeriki SG, Gudkova RB. Important problems in the diagnosis and treatment of autoimmune hepatitis (based on the Russian consensus 2017). Ter Arkh 2018;90:12-8. [PMID: 30701766 DOI: 10.26442/terarkh201890212-18] [Reference Citation Analysis]
10 Alves SC, Fasano S, Isenberg DA. Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review. Lupus 2016;25:1509-19. [PMID: 27329649 DOI: 10.1177/0961203316655210] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
11 Milić S, Tatalović T, Mikolašević I. Pre-existing liver disease in pregnancy: Cirrhosis, autoimmune hepatitis and liver transplantation. Best Pract Res Clin Gastroenterol 2020;44-45:101668. [PMID: 32359683 DOI: 10.1016/j.bpg.2020.101668] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Weiler-normann C, Lohse AW. Autoimmune hepatitis: A life-long disease. Journal of Hepatology 2013;58:5-7. [DOI: 10.1016/j.jhep.2012.10.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
13 Terziroli Beretta-piccoli B, Invernizzi P, Gershwin ME, Mainetti C. Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review. Clinic Rev Allerg Immunol 2017;53:394-412. [DOI: 10.1007/s12016-017-8649-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
14 Lohse AW, Wiegard C. Diagnostic criteria for autoimmune hepatitis. Best Practice & Research Clinical Gastroenterology 2011;25:665-71. [DOI: 10.1016/j.bpg.2011.10.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
15 Invernizzi P. Liver auto-immunology: the paradox of autoimmunity in a tolerogenic organ. J Autoimmun. 2013;46:1-6. [PMID: 24012346 DOI: 10.1016/j.jaut.2013.08.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
16 Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World J Gastroenterol 2017; 23(33): 6030-6048 [PMID: 28970719 DOI: 10.3748/wjg.v23.i33.6030] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 45] [Article Influence: 11.8] [Reference Citation Analysis]
17 Kaneko A, Tatsumi T, Yakushijin T, Hiramatsu N, Mita E, Nakanishi F, Oshita M, Yoshihara H, Imai Y, Fukui H, Kobayashi I, Doi Y, Hayashi E, Tsutsui S, Shibukawa N, Tatsumi N, Hori Y, Morii E, Takehara T. Present status of steroid administration to patients with autoimmune hepatitis and factors associated with relapse. Acta hepatologica Japonica 2015;56:507-17. [DOI: 10.2957/kanzo.56.507] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Weiler-Normann C, Schramm C, Quaas A, Wiegard C, Glaubke C, Pannicke N, Möller S, Lohse AW. Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis. J Hepatol. 2013;58:529-534. [PMID: 23178709 DOI: 10.1016/j.jhep.2012.11.010] [Cited by in Crossref: 135] [Cited by in F6Publishing: 112] [Article Influence: 13.5] [Reference Citation Analysis]
19 van Gerven NM, de Boer YS, Mulder CJ, van Nieuwkerk CM, Bouma G. Auto immune hepatitis. World J Gastroenterol 2016; 22(19): 4651-4661 [PMID: 27217697 DOI: 10.3748/wjg.v22.i19.4651] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
20 Dyson JK, De Martin E, Dalekos GN, Drenth JP, Herkel J, Hubscher SG, Kelly D, Lenzi M, Milkiewicz P, Oo YH, Heneghan MA, Lohse AW; the IAIHG Consortium. Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop. Aliment Pharmacol Ther 2019;49:528-36. [DOI: 10.1111/apt.15111] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
21 . EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology 2015;63:971-1004. [DOI: 10.1016/j.jhep.2015.06.030] [Cited by in Crossref: 489] [Cited by in F6Publishing: 395] [Article Influence: 69.9] [Reference Citation Analysis]
22 Nadhem ON, Janabi MA, Omer AR, Wan B. Autoimmune hepatitis with multiple sclerosis and graves disease: coincidence or association? Case Rep Gastroenterol 2014;8:319-23. [PMID: 25473390 DOI: 10.1159/000368551] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
23 Gutkowski K, Hartleb M, Kacperek-Hartleb T, Kajor M, Mazur W, Zych W, Walewska-Zielecka B, Habior A, Sobolewski M. Laboratory-based scoring system for prediction of hepatic inflammatory activity in patients with autoimmune hepatitis. Liver Int. 2013;33:1370-1377. [PMID: 23651331 DOI: 10.1111/liv.12198] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
24 Khan FM, Alcorn J, Hanson J. A case of jaundice of obscure origin. Dig Dis Sci 2014;59:933-6. [PMID: 24691629 DOI: 10.1007/s10620-014-3114-6] [Reference Citation Analysis]
25 Rojas CP, Bodicharla R, Campuzano-Zuluaga G, Hernandez L, Rodriguez MM. Autoimmune hepatitis and primary sclerosing cholangitis in children and adolescents. Fetal Pediatr Pathol. 2014;33:202-209. [PMID: 24754367 DOI: 10.3109/15513815.2014.898721] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
26 Rangel MA, Pinto Pais I, Duarte R, Carvalho I. Antituberculosis Drug-Induced Liver Injury with Autoimmune Features: Facing Diagnostic and Treatment Challenges. Case Rep Pediatr 2017;2017:5741896. [PMID: 28116201 DOI: 10.1155/2017/5741896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Sucher E, Sucher R, Gradistanac T, Brandacher G, Schneeberger S, Berg T. Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies. J Immunol Res 2019;2019:9437043. [PMID: 31886312 DOI: 10.1155/2019/9437043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
28 Vergani D, Terziroli Beretta-Piccoli B, Mieli-Vergani G. A reasoned approach to the treatment of autoimmune hepatitis. Dig Liver Dis 2021:S1590-8658(21)00307-8. [PMID: 34162505 DOI: 10.1016/j.dld.2021.05.033] [Reference Citation Analysis]
29 Liberal R, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: From mechanisms to therapy. Rev Clin Esp. 2016;216:372-383. [PMID: 27161382 DOI: 10.1016/j.rce.2016.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
30 Mikolasevic I, Filipec-Kanizaj T, Jakopcic I, Majurec I, Brncic-Fischer A, Sobocan N, Hrstic I, Stimac T, Stimac D, Milic S. Liver Disease During Pregnancy: A Challenging Clinical Issue. Med Sci Monit 2018;24:4080-90. [PMID: 29905165 DOI: 10.12659/MSM.907723] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 6.8] [Reference Citation Analysis]
31 Caballero-Mateos AM, López Garrido MÁ, Becerra Massare P, de Teresa Galván J. Autoimmune severe acute fulminant hepatic failure (FHF) during pregnancy. Gastroenterol Hepatol 2018;41:259-60. [PMID: 28579277 DOI: 10.1016/j.gastrohep.2017.04.001] [Reference Citation Analysis]
32 Zhao Y, Li Y, Zhao D, Zhang H, Liu Y, Liao H, Zhang Y, Yan H. Fumarate hydratase-specific T cell response in Chinese patients with autoimmune hepatitis. Clin Res Hepatol Gastroenterol 2018;42:339-46. [PMID: 29610041 DOI: 10.1016/j.clinre.2017.12.003] [Reference Citation Analysis]
33 Cropley A, Weltman M. The use of immunosuppression in autoimmune hepatitis: A current literature review. Clin Mol Hepatol 2017;23:22-6. [PMID: 28288505 DOI: 10.3350/cmh.2016.0089] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
34 Liberal R, Krawitt EL, Vierling JM, Manns MP, Mieli-Vergani G, Vergani D. Cutting edge issues in autoimmune hepatitis. J Autoimmun. 2016;75:6-19. [PMID: 27502148 DOI: 10.1016/j.jaut.2016.07.005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 9.7] [Reference Citation Analysis]
35 Su CW, Yang YY, Lin HC. Impact of etiological treatment on prognosis. Hepatol Int 2018;12:56-67. [PMID: 28702738 DOI: 10.1007/s12072-017-9807-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
36 Li H, Li G, Zhao X, Wu Y, Ma W, Liu Y, Gong F, Liang S. Complementary serum proteomic analysis of autoimmune hepatitis in mice and patients. J Transl Med 2013;11:146. [PMID: 23763817 DOI: 10.1186/1479-5876-11-146] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
37 Gossard AA, Talwalkar JA. A 48-year-old woman with a new diagnosis of autoimmune hepatitis. Clin Gastroenterol Hepatol 2012;10:980-3. [PMID: 22610007 DOI: 10.1016/j.cgh.2012.04.022] [Reference Citation Analysis]
38 Covelli C, Sacchi D, Sarcognato S, Cazzagon N, Grillo F, Baciorri F, Fanni D, Cacciatore M, Maffeis V, Guido M. Pathology of autoimmune hepatitis. Pathologica 2021;113:185-93. [PMID: 34294936 DOI: 10.32074/1591-951X-241] [Reference Citation Analysis]
39 Chaouali M, Azaiez MB, Tezeghdenti A, Lagha A, Yacoubi-Oueslati B, Ghazouani E, Abdallah HB, Kochkar R. Association of TNF-α-308 Polymorphism with Susceptibility to Autoimmune Hepatitis in Tunisians. Biochem Genet 2018;56:650-62. [PMID: 29845365 DOI: 10.1007/s10528-018-9867-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Roepe IG, Vierling JM, Goss JA, Miloh T. Presentation and Outcomes of Autoimmune Hepatitis Type 1 and Type 2 in Children: A Single-center Study. J Pediatr Gastroenterol Nutr 2021;72:101-7. [PMID: 32796427 DOI: 10.1097/MPG.0000000000002892] [Reference Citation Analysis]
41 Yousefi A, Mahmoudi E, Baradaran Noveiry B, Zare Bidoki A, Sadr M, Motamed F, Najafi M, Farahmand F, Khodadad A, Fallahi GH, Rezaei N. Autoimmune hepatitis association with single nucleotide polymorphism of interleukin-2, but not interferon-gamma. Clinics and Research in Hepatology and Gastroenterology 2018;42:134-8. [DOI: 10.1016/j.clinre.2017.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
42 Liberal R, Vergani D, Mieli-Vergani G. Update on Autoimmune Hepatitis. J Clin Transl Hepatol. 2015;3:42-52. [PMID: 26357634 DOI: 10.14218/jcth.2014.00032] [Cited by in Crossref: 58] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
43 Wang QX, Jiang WJ, Miao Q, Xiao X, Zhang HY, Huang SS, Shen L, Hua J, Li H, Li S. Clinical and histological features of autoantibody-negative autoimmune hepatitis in Chinese patients: a single center experience. J Dig Dis. 2013;14:175-180. [PMID: 23216916 DOI: 10.1111/1751-2980.12022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
44 Wobser H, Paur T, Schnoy E, Hartl J, Kirchner GI. Suitability of the simplified autoimmune hepatitis score for the diagnosis of autoimmune hepatitis in a German cohort. United European Gastroenterol J 2018;6:247-54. [PMID: 29511554 DOI: 10.1177/2050640617711632] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
45 Peña-Vélez R, Almanza-Miranda E. [Autoimmune hepatitis in the pediatric age]. Bol Med Hosp Infant Mex 2017;74:324-33. [PMID: 29382475 DOI: 10.1016/j.bmhimx.2017.05.004] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Della Corte C, Sartorelli MR, Sindoni CD, Girolami E, Giovannelli L, Comparcola D, Nobili V. Autoimmune hepatitis in children: an overview of the disease focusing on current therapies. European Journal of Gastroenterology & Hepatology 2012;24:739-46. [DOI: 10.1097/meg.0b013e328353750c] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
47 Liu F, Pan ZG, Ye J, Xu D, Guo H, Li GP, Xu KS, Hou XH, Song YH. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: simplified criteria may be effective in the diagnosis in Chinese patients. J Dig Dis. 2014;15:660-668. [PMID: 25236944 DOI: 10.1111/1751-2980.12196] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
48 Ferguson LA. Autoimmune hepatitis: a noninfectious killer. J Am Assoc Nurse Pract 2014;26:13-8. [PMID: 24170733 DOI: 10.1002/2327-6924.12055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
49 Webb GJ, Hirschfield GM. Using GWAS to identify genetic predisposition in hepatic autoimmunity. J Autoimmun. 2016;66:25-39. [PMID: 26347073 DOI: 10.1016/j.jaut.2015.08.016] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 9.6] [Reference Citation Analysis]
50 Patel AM, Stanback C, Vellanki P. Clinical Case Report: Dissociation of Clinical Course of Coexisting Autoimmune Hepatitis and Graves Disease. AACE Clin Case Rep 2021;7:36-9. [PMID: 33851017 DOI: 10.1016/j.aace.2020.11.007] [Reference Citation Analysis]
51 Corrigan M, Hirschfield GM, Oo YH, Adams DH. Autoimmune hepatitis: an approach to disease understanding and management. Br Med Bull 2015;114:181-91. [DOI: 10.1093/bmb/ldv021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
52 Moy L, Levine J. Autoimmune hepatitis: a classic autoimmune liver disease. Curr Probl Pediatr Adolesc Health Care. 2014;44:341-346. [PMID: 25466500 DOI: 10.1016/j.cppeds.2014.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
53 Liang JB, Chen Y, Chen RL, Li YK, Li B, You ZR, Li Y, Zhang J, Huang BY, Wei YR, Lyu ZW, Lian M, Xiao X, Wang QX, Tang RQ, Fang JY, Chen XY, Ma X, Miao Q. CD8+ T cells actively penetrate hepatocytes via the CD44/p-ERM/F-actin pathway in autoimmune hepatitis. J Dig Dis 2021;22:351-62. [PMID: 33928766 DOI: 10.1111/1751-2980.12995] [Reference Citation Analysis]
54 Podgórska J, Werel P, Klapaczyński J, Orzechowska D, Wudarski M, Gietka A. Liver involvement in rheumatic diseases. Reumatologia 2020;58:289-96. [PMID: 33227094 DOI: 10.5114/reum.2020.99782] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Theocharidou E, Heneghan MA. Current and future perspectives in autoimmune hepatitis. Br J Hosp Med (Lond) 2018;79:151-9. [PMID: 29528732 DOI: 10.12968/hmed.2018.79.3.151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Di Sabatino A, Biagi F, Lenzi M, Frulloni L, Lenti MV, Giuffrida P, Corazza GR. Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases. Digestive and Liver Disease 2017;49:947-56. [DOI: 10.1016/j.dld.2017.06.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
57 Cerda Reyes E, González-Navarro EA, Magaz M, Muñoz-Sánchez G, Diaz A, Silva-Junior G, Triguero A, Lafoz E, Campreciós G, Orts L, Perez-Campuzano V, Seijo S, Rubio L, Turon F, Baiges A, Hernández-Gea V, Álvarez-Larran A, Juan M, Garcia-Pagan JC. Autoimmune biomarkers in porto-sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology. Liver Int 2021;41:2171-8. [PMID: 34173316 DOI: 10.1111/liv.14997] [Reference Citation Analysis]
58 Eugène C. Comment on the British Society of Gastroenterology guidelines for management of autoimmune hepatitis (part 1). Clin Res Hepatol Gastroenterol 2012;36:408-11. [PMID: 22634113 DOI: 10.1016/j.clinre.2012.04.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Narciso-Schiavon JL, Schiavon LL. To screen or not to screen? Celiac antibodies in liver diseases. World J Gastroenterol 2017; 23(5): 776-791 [PMID: 28223722 DOI: 10.3748/wjg.v23.i5.776] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
60 Sato A, Sano F, Ishii T, Adachi K, Negishi R, Matsumoto N, Okuse C. Pure red cell aplasia associated with autoimmune hepatitis successfully treated with cyclosporine A. Clin J Gastroenterol 2014;7:74-8. [PMID: 24523831 DOI: 10.1007/s12328-013-0448-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Than NN, Jeffery HC, Oo YH. Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy. Can J Gastroenterol Hepatol 2016;2016:7181685. [PMID: 27446862 DOI: 10.1155/2016/7181685] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
62 Italian Association for the Study of the Liver (AISF); Italian Association for the Study of the Liver AISF. AISF position paper on liver disease and pregnancy. Dig Liver Dis. 2016;48:120-137. [PMID: 26747754 DOI: 10.1016/j.dld.2015.11.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
63 Adiga A, Nugent K. Lupus Hepatitis and Autoimmune Hepatitis (Lupoid Hepatitis). The American Journal of the Medical Sciences 2017;353:329-35. [DOI: 10.1016/j.amjms.2016.10.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
64 Pathak S, Kamat D. Autoimmune Hepatitis in Children. Pediatr Ann 2018;47:e81-6. [PMID: 29446799 DOI: 10.3928/19382359-20180126-01] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
65 Aljumah AA, Al Jarallah B, Albenmousa A, Al Khathlan A, Al Zanbagi A, Al Quaiz M, Al-Judaibi B, Nabrawi K, Al Hamoudi W, Alghamdi M, Fallatah H. The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis. Saudi J Gastroenterol 2018;24:S1-S20. [PMID: 30264737 DOI: 10.4103/sjg.SJG_159_18] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Brahim I, Brahim I, Hazime R, Admou B. [Autoimmune hepatitis: Immunological diagnosis]. Presse Med 2017;46:1008-19. [PMID: 28919271 DOI: 10.1016/j.lpm.2017.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
67 Miao Q, Bian Z, Tang R, Zhang H, Wang Q, Huang S, Xiao X, Shen L, Qiu D, Krawitt EL, Gershwin ME, Ma X. Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis. Clin Rev Allergy Immunol 2015;48:226-35. [PMID: 25051956 DOI: 10.1007/s12016-014-8432-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
68 Calisti G, Irish DN, Ijaz S, Tedder RS, Moore K.  Acute hepatitis E mimicking a flare of disease in a patient with chronic autoimmune hepatitis. Ann Hepatol 2017;16:160-3. [PMID: 28051806 DOI: 10.5604/16652681.1226952] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
69 Kobayashi M, Kakuda Y, Harada K, Sato Y, Sasaki M, Ikeda H, Terada M, Mukai M, Kaneko S, Nakanuma Y. Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis. World J Gastroenterol 2014; 20(13): 3597-3608 [PMID: 24707143 DOI: 10.3748/wjg.v20.i13.3597] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
70 Beisel C, Weiler-Normann C, Teufel A, Lohse AW. Association of autoimmune hepatitis and systemic lupus erythematodes: A case series and review of the literature. World J Gastroenterol 2014; 20(35): 12662-12667 [PMID: 25253972 DOI: 10.3748/wjg.v20.i35.12662] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
71 Fan X, Zhu Y, Men R, Wen M, Shen Y, Lu C, Yang L. Efficacy and Safety of Immunosuppressive Therapy for PBC-AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study. Can J Gastroenterol Hepatol 2018;2018:1965492. [PMID: 30155449 DOI: 10.1155/2018/1965492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Hartl J, Ehlken H, Weiler-Normann C, Sebode M, Kreuels B, Pannicke N, Zenouzi R, Glaubke C, Lohse AW, Schramm C. Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis. J Hepatol. 2015;62:642-646. [PMID: 25457202 DOI: 10.1016/j.jhep.2014.10.018] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
73 Trivedi PJ, Hirschfield GM. Treatment of autoimmune liver disease: curr ent and future therapeutic options. Ther Adv Chronic Dis. 2013;4:119-141. [PMID: 23634279 DOI: 10.1177/2040622313478646] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
74 Zhu S, Zhang H, Dong Y, Xu Z, Chen D, Wang L, Gan Y, Wang F, Wang Y, Xing X. The correlation between T helper type 17 cells and clinical characters in Chinese paediatric patients with chronic hepatitis B. Clin Exp Immunol. 2013;171:307-312. [PMID: 23379437 DOI: 10.1111/cei.12028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
75 Sabapathy DG, Desai MS. Acute Liver Failure in Children. Pediatr Clin North Am 2022;69:465-95. [PMID: 35667757 DOI: 10.1016/j.pcl.2022.02.003] [Reference Citation Analysis]
76 Goyes D, Malladi VR, Ishtiaq R, Al-Khazraji A. Case of autoimmune hepatitis with overlap systemic lupus erythematosus. BMJ Case Rep 2020;13:e237341. [PMID: 33376090 DOI: 10.1136/bcr-2020-237341] [Reference Citation Analysis]
77 Mühling T, Rohrbach H, Schepp W, Gundling F. Overlap of concurrent extrahepatic autoimmune diseases is associated with milder disease severity of newly diagnosed autoimmune hepatitis. Hepatobiliary Pancreat Dis Int 2021;20:21-7. [PMID: 32830050 DOI: 10.1016/j.hbpd.2020.06.019] [Reference Citation Analysis]
78 Díaz-Ramírez GS, Marín-Zuluaga JI, Donado-Gómez JH, Muñoz-Maya O, Santos-Sánchez Ó, Restrepo-Gutiérrez JC. Characterization of patients with autoimmune hepatitis at an university hospital in Medellín-Colombia: cohort study. Gastroenterol Hepatol 2018;41:87-96. [PMID: 29126693 DOI: 10.1016/j.gastrohep.2017.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
79 Manns MP, Lohse AW, Vergani D. Autoimmune hepatitis--Update 2015. J Hepatol. 2015;62:S100-S111. [PMID: 25920079 DOI: 10.1016/j.jhep.2015.03.005] [Cited by in Crossref: 164] [Cited by in F6Publishing: 138] [Article Influence: 27.3] [Reference Citation Analysis]
80 Janmohamed A, Hirschfield GM. Autoimmune hepatitis and complexities in management. Frontline Gastroenterol 2019;10:77-87. [PMID: 30651962 DOI: 10.1136/flgastro-2018-101015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
81 Dalekos GN, Koskinas J, Papatheodoridis GV. Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitis. Ann Gastroenterol 2019;32:1-23. [PMID: 30598587 DOI: 10.20524/aog.2018.0330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
82 Weiler-normann C, Lohse AW. Acute autoimmune hepatitis: Many open questions. Journal of Hepatology 2014;61:727-9. [DOI: 10.1016/j.jhep.2014.06.030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
83 Della Corte C, Mosca A, Vania A, Alterio A, Alisi A, Nobili V. Pediatric liver diseases: current challenges and future perspectives. Expert Rev Gastroenterol Hepatol 2016;10:255-65. [PMID: 26641319 DOI: 10.1586/17474124.2016.1129274] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
84 Liberal R, Mieli-vergani G, Vergani D. Autoimmune hepatitis: From mechanisms to therapy. Revista Clínica Española (English Edition) 2016;216:372-83. [DOI: 10.1016/j.rceng.2016.04.004] [Reference Citation Analysis]
85 Sebode M, Schramm C, Lohse AW. [Inflammatory diseases with liver and joint involvement. A differential diagnostic challenge]. Internist (Berl) 2013;54:441-8. [PMID: 23455625 DOI: 10.1007/s00108-012-3191-6] [Reference Citation Analysis]
86 Hartl J, Ehlken H, Sebode M, Peiseler M, Krech T, Zenouzi R, von Felden J, Weiler-Normann C, Schramm C, Lohse AW. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis. J Hepatol. 2017; Epub ahead of print. [PMID: 29180000 DOI: 10.1016/j.jhep.2017.11.020] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
87 Xu Q, Sheng L, Bao H, Chen X, Guo C, Li H, Ma X, Qiu D, Hua J. Evaluation of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis. J Gastroenterol Hepatol. 2017;32:639-644. [PMID: 27505153 DOI: 10.1111/jgh.13508] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
88 Park SW, Um SH, Lee HA, Kim SH, Sim Y, Yim SY, Seo YS, Ryu HS. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis. Clin Mol Hepatol. 2016;22:281-285. [PMID: 27246353 DOI: 10.3350/cmh.2015.0040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
89 Wang H, Wang J, Xia J, Yan X, Feng Y, Li L, Chen J, Liu D, Ding W, Yang Y, Huang R, Wu C. Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitis. Medicine (Baltimore) 2020;99:e21408. [PMID: 32846758 DOI: 10.1097/MD.0000000000021408] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 Jensen MD, Jepsen P, Vilstrup H, Grønbæk L. Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study. Am J Gastroenterol 2021. [PMID: 34622808 DOI: 10.14309/ajg.0000000000001525] [Reference Citation Analysis]
91 van den Brand FF, van der Veen KS, Lissenberg-Witte BI, de Boer YS, van Hoek B, Drenth JPH, Verdonk RC, Vrolijk JM, van Nieuwkerk CMJ, Bouma G; Dutch Autoimmune Hepatitis Study Group. Adverse events related to low dose corticosteroids in autoimmune hepatitis. Aliment Pharmacol Ther 2019;50:1120-6. [PMID: 31617229 DOI: 10.1111/apt.15528] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
92 Zachou K, Muratori P, Koukoulis GK, Granito A, Gatselis N, Fabbri A, Dalekos GN, Muratori L. Review article: autoimmune hepatitis -- current management and challenges. Aliment Pharmacol Ther. 2013;38:887-913. [PMID: 24010812 DOI: 10.1111/apt.12470] [Cited by in Crossref: 110] [Cited by in F6Publishing: 95] [Article Influence: 12.2] [Reference Citation Analysis]
93 Eugene C. Comment on the British Society of Gastroenterology guidelines for management of autoimmune hepatitis (part 2). Clin Res Hepatol Gastroenterol 2012;36:521-3. [PMID: 22925553 DOI: 10.1016/j.clinre.2012.06.009] [Reference Citation Analysis]
94 Bozzini AB, Neder L, Silva CA, Porta G. Decreased health-related quality of life in children and adolescents with autoimmune hepatitis. Jornal de Pediatria 2019;95:87-93. [DOI: 10.1016/j.jped.2017.10.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
95 Liberal R, Mieli-Vergani G, Vergani D. Contemporary issues and future directions in autoimmune hepatitis. Expert Rev Gastroenterol Hepatol 2016;10:1163-74. [PMID: 27215278 DOI: 10.1080/17474124.2016.1193004] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
96 Duclos-Vallée JC, Debray D, De Martin E, Beux EL, Louvet A. Best practice guidelines for France regarding the diagnosis and management of autoimmune hepatitis. Clin Res Hepatol Gastroenterol 2022;:101871. [PMID: 35108657 DOI: 10.1016/j.clinre.2022.101871] [Reference Citation Analysis]
97 Landi A, Weismuller TJ, Lankisch TO, Santer DM, Tyrrell DL, Manns MP, Houghton M. Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis. J Interferon Cytokine Res. 2014;34:204-214. [PMID: 24168449 DOI: 10.1089/jir.2013.0075] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
98 Tanaka A. Acute presentation of autoimmune hepatitis: How to find and manage still remains unsolved. Hepatol Res 2013;43:577-9. [PMID: 23730706 DOI: 10.1111/hepr.12031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
99 Muratori P, Granito A, Lenzi M, Muratori L. Limitation of the simplified scoring system for the diagnosis of autoimmune Hepatitis with acute onset. Liver Int 2021;41:529-34. [PMID: 33389800 DOI: 10.1111/liv.14778] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
100 Hübscher SG. Role of liver biopsy in autoimmune liver disease. Diagnostic Histopathology 2014;20:109-18. [DOI: 10.1016/j.mpdhp.2014.01.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
101 Pape S, Gevers TJG, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, Taubert R, Jaeckel E, Manns MP, Papp M, Sipeki N, Stickel F, Efe C, Ozaslan E, Purnak T, Nevens F, Kessener DJN, Kahraman A, Wedemeyer H, Hartl J, Schramm C, Lohse AW, Heneghan MA, Drenth JPH. High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation. Liver Int 2020;40:2164-71. [PMID: 32410363 DOI: 10.1111/liv.14513] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
102 Violatto MB, Casarin E, Talamini L, Russo L, Baldan S, Tondello C, Messmer M, Hintermann E, Rossi A, Passoni A, Bagnati R, Biffi S, Toffanin C, Gimondi S, Fumagalli S, De Simoni MG, Barisani D, Salmona M, Christen U, Invernizzi P, Bigini P, Morpurgo M. Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model. ACS Nano 2019;13:4410-23. [PMID: 30883091 DOI: 10.1021/acsnano.8b09655] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
103 Anand L, Choudhury A, Bihari C, Sharma BC, Kumar M, Maiwall R, Siam Tan S, Shah SR, Hamid S, Butt AS, Jafri W, Chawla YK, Taneja S, Duseja A, Dhiman RK, Mahtab MA, Ghazinyan H, Duan Z, Chen Y, Shukla A, Hu J, Abbas Z, Treeprasertsuk S, Lesmana LA, Lesmana CR, Sollano JD, Carpio G, Sahu MK, Kumar G, Sarin SK; APASL ACLF (APASL ACLF Research Consortium) Working Party. Flare of Autoimmune Hepatitis Causing Acute on Chronic Liver Failure: Diagnosis and Response to Corticosteroid Therapy. Hepatology 2019;70:587-96. [PMID: 30113706 DOI: 10.1002/hep.30205] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 11.7] [Reference Citation Analysis]
104 Klein R, Hintz E, Staehler G. Exacerbation of AIH in a patient with an AIH/systemic sclerosis overlap syndrome and pulmonary arterial hypertension treated with the endothelin-1 receptor antagonist sitaxentan. BMJ Case Rep. 2012;2012. [PMID: 22802555 DOI: 10.1136/bcr-01-2012-5494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
105 Bittencourt PL, Cançado ELR, Couto CA, Levy C, Porta G, Silva AEB, Terrabuio DRB, Carvalho Filho RJD, Chaves DM, Miura IK, Codes L, Faria LC, Evangelista AS, Farias AQ, Gonçalves LL, Harriz M, Lopes Neto EPA, Luz GO, Oliveira P, Oliveira EMGD, Schiavon JLN, Seva-pereira T, Parise ER. Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liver. Arq Gastroenterol 2015;52:15-46. [DOI: 10.1590/s0004-28032015000500002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
106 Schwinge D, Schramm C. Sex-related factors in autoimmune liver diseases. Semin Immunopathol 2019;41:165-75. [DOI: 10.1007/s00281-018-0715-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
107 Braga A, Vasconcelos C, Braga J. Autoimmune hepatitis and pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology 2020;68:23-31. [DOI: 10.1016/j.bpobgyn.2020.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Schultheiß C, Steinmann S, Lohse AW, Binder M. B cells in autoimmune hepatitis: bystanders or central players? Semin Immunopathol 2022. [PMID: 35488094 DOI: 10.1007/s00281-022-00937-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Selvarajah V, Montano-loza AJ, Czaja AJ. Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. Aliment Pharmacol Ther 2012;36:691-707. [DOI: 10.1111/apt.12042] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
110 Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, Lohse AW, Montano-Loza AJ. Autoimmune hepatitis. Nat Rev Dis Primers. 2018;4:18017. [PMID: 29644994 DOI: 10.1038/nrdp.2018.17] [Cited by in Crossref: 92] [Cited by in F6Publishing: 83] [Article Influence: 23.0] [Reference Citation Analysis]
111 Shiani A, Narayanan S, Pena L, Friedman M. The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer. Cancer Control 2017;24:1073274817729240. [PMID: 28975833 DOI: 10.1177/1073274817729240] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
112 Téllez L, Sánchez Rodríguez E, Rodríguez de Santiago E, Llovet L, Gómez-Outomuro A, Díaz-Fontenla F, Álvarez López P, García-Eliz M, Amaral C, Sánchez-Torrijos Y, Fortea JI, Ferre-Aracil C, Rodríguez-Perálvarez M, Abadía M, Gómez-Camarero J, Olveira A, Calleja JL, Crespo J, Romero M, Hernández-Guerra M, Berenguer M, Riveiro-Barciela M, Salcedo M, Rodríguez M, Londoño MC, Albillos A. Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study. Aliment Pharmacol Ther 2022;56:131-43. [PMID: 35470447 DOI: 10.1111/apt.16926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Ma X, Qiu K. Chinese consensus on the diagnosis and management of autoimmune hepatitis (2015): Chinese Society of Hepatology, Chinese Society of Gastroenterology & amp; Chinese Society of Infectious Diseases. J Dig Dis. 2017; Apr 27. [Epub ahead of print]. [PMID: 28449401 DOI: 10.1111/1751-2980.12479] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
114 Braga A, Braga J. Successful pregnancy with autoimmune cirrhosis. BMJ Case Rep 2016;2016:bcr2015212501. [PMID: 26825934 DOI: 10.1136/bcr-2015-212501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]